Sua ao inovadora como agonista duplo de GLP-1 e GIP possibilita benefcios metablicos ampliados e sustentados, indo alm do que se observa com terapias tradicionais
Tirzepatide is a once-weekly injectable medication that helps with weight loss by: Regulating Hunger Hormones Reduces cravings and controls appetite naturally Boosting Metabolism Enhances your body's ability to burn calories efficiently Balancing Blood Sugar Improves glucose control and reduces energy crashes Slowing Digestion Keeps you feeling full longer, preventing overeating Unlike other weight loss treatments, Tirzepatide is the first and only medication that activates two key hormone receptors (GLP-1 and GIP), making it more effective at reducing body fat while preserving lean muscle mass
doi: 10.3389/fphar.2024.1383203 Received 07 February 2024 Accepted 02 April 2024 Published 11 April 2024 Volume 15 - 2024 Edited by Masamitsu Kanada, Michigan State University, United States Reviewed by Anas Shamsi, Ajman University, United Arab Emirates Ang Luo, Northwest A&F University, China Updates Copyright 2024 Din, Lin, Wang, Wang and Mao
Consistent weekly dosing is crucial to achieving optimal results
Serious allergic reactions are uncommon but possible
Because the drug slows the release of digested food from your stomach, it may affect how certain oral medications are absorbed by your body when theyre taken together, including other blood sugar-lowering medications